4.4 Article

Pharmacodynamic and Pharmacokinetic Profiles of Sacubitril/Valsartan (LCZ696) in Patients with Heart Failure and Reduced Ejection Fraction

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Letter Cardiac & Cardiovascular Systems

Combined angiotensin receptor blockade and neprilysin inhibition attenuates angiotensin-II mediated renal cellular collagen synthesis

Bing H. Wang et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)

Letter Cardiac & Cardiovascular Systems

Neprilysin inhibitors preserve renal function in heart failure

Fiona Bodey et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)

Article Medicine, General & Internal

Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure

John J. V. McMurray et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Cardiac & Cardiovascular Systems

Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics

Sarah Mangiafico et al.

EUROPEAN HEART JOURNAL (2013)

Article Cardiac & Cardiovascular Systems

Biology of the natriuretic peptides

Abelardo Martinez-Rumayor et al.

AMERICAN JOURNAL OF CARDIOLOGY (2008)

Article Urology & Nephrology

Hormonal and hemodynamic effects of aliskiren and valsartan and their combination in sodium-replete normotensive individuals

Michel Azizi et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)

Review Cell Biology

Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system

Puja K. Mehta et al.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)

Article Pharmacology & Pharmacy

Pharmacokinetics and pharmacodynamics of the vasopeptidase inhibitor, omapatrilat in healthy subjects

WC Liao et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)

Article Cardiac & Cardiovascular Systems

Pharmacokinetics of multiple doses of valsartan in patients with heart failure

PP Prasad et al.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2002)